Ilya Pharma approved for funding by the European Innovation Council Equity Fund for high-impact innovation
Ilya Pharma is one of the first companies to be approved for equity funding by the EIC Fund as part of winning the EIC Accelerator program for blended financing with WHILYAS-2. Following thorough due diligence by multiple industrial experts and the EIB a term sheet is in place and the company is now aiming to close the round inviting current and external investors.
Link to post: https://www.bloomberg.com/news/articles/2021-01-06/eu-will-become-shareholder-in-startups-for-the-first-time
Link to list for Swedish companies shortlisted for investment (in Swedish):
Link to more information about the EIC Fund:https://ec.europa.eu/info/news/official-entity-european-innovation-council-equity-fund-high-impact-innovation-2020-jun-22_en